Drawing for BIOEPCIN-JECT

USPTO serial 98483727

BIOEPCIN-JECT

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SMITH, BRENDAN K
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with BIOEPCIN-JECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bentley J. Olive

Bentley J. Olive Olive Law Group, PLLC2500 Regency ParkwayCary, NC 27518United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical compositions and preparations, namely, pharmaceutical compositions and preparations of the immunomodulator Glatiramer Acetate for treatment of multiple sclerosisACTIVE—
010Medical apparatus, devices and instruments, namely, fluid injectors for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 15, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 15, 2026EX3GSOU EXTENSION 3 GRANTED—
Jul 15, 2026EXT3SOU EXTENSION 3 FILED—
Jul 15, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 3, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 3, 2026EX2GSOU EXTENSION 2 GRANTED—
Feb 3, 2026EXT2SOU EXTENSION 2 FILED—
Feb 3, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 16, 2025EX1GSOU EXTENSION 1 GRANTED—
Jul 16, 2025EXT1SOU EXTENSION 1 FILED—
Jul 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 10, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 18, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Oct 18, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 18, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 18, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 17, 2024DOCKASSIGNED TO EXAMINER—
Sep 10, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 4, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance